Skip to main content

UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks

Inquiry

The Coronavirus COVID-19 outbreak is the latest in a series of disease outbreaks that have spread internationally, presenting major challenges to communities, national governments and international institutions. 

Scientific knowledge and advice are foundational to the prevention, management and treatment of these global outbreaks, at both an international and national level. 

Once the COVID-19 pandemic has passed its peak, it will be necessary for international and national systems to learn from the crisis. The Science and Technology Committee will inquire formally into the place of UK research, science and technology in the national and global response, and what lessons should be learned for the future. 

Reports and government responses

No reports or government responses published

Oral evidence transcripts

View all oral evidence transcripts
21 July 2020
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Rt Hon Matt Hancock MP (Secretary of State for Health and Social Care at Department for Health and Social Care), and Sir Chris Wormald (Permanent Secretary at Department for Health and Social Care)
Committees Science and Technology Committee (Commons)
Oral Evidence
16 July 2020
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Sir Patrick Vallance, Government Chief Scientific Adviser
Committees Science and Technology Committee (Commons)
Oral Evidence
1 July 2020
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Sarah Gilbert (Professor of Vaccinology at University of Oxford), Kate Bingham (Chair at UK Government Vaccine Taskforce), Professor Sir John Bell (Regius Professor of Medicine at University of Oxford), Professor Jonathan Van-Tam (Deputy Chief Medical Officer and Lead, Therapeutics Taskforce at Department for Health and Social Care), and Dr Jonathan Sheffield (Covid-19 Research Operations Director at National Institute for Health Research)
Committees Science and Technology Committee (Commons)
Oral Evidence
Witnesses Dr G D Barr
Committees Science and Technology Committee (Commons)
Written Evidence
Witnesses University College London
Committees Science and Technology Committee (Commons)
Written Evidence
Witnesses Peter Hebard (Covid Task Force Coordinator at IMechE Covid Task Force)
Committees Science and Technology Committee (Commons)
Written Evidence

Contact us

We can’t usually help you with an individual problem or a specific complaint.

  • Email: scitechcom@parliament.uk
  • Phone: 020 7219 2793 (General enquiries) / 020 7219 3172 (Media enquiries) / 18001 20 7219 2793 (text relay)
  • Address: Science and Technology Committee, House of Commons, London, SW1A 0AA